The impact of the COVID-19 pandemic on the epidemiology, clinical manifestations and molecular characteristics of Mycoplasma pneumoniae
Mycoplasma pneumoniae (MP) is a major causative agent of acute respiratory tract infections in children. Since 2023, its high prevalence coupled with rising rates of macrolide resistance has presented substantial challenges in the clinical management o…